Milestone Pharmaceuticals Inc. (MIST)
CIK 1408443 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Milestone Pharmaceuticals Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 3, 2026 | 8-K | 0001104659-26-105052 |
| Aug 12, 2026 | 8-K | 0001104659-26-094466 |
| Aug 12, 2026 | 10-Q | 0001104659-26-094435 |
| Aug 7, 2026 | SCHEDULE 13G | 0002143027-26-000012 |
| Jun 15, 2026 | 8-K | 0001104659-26-074025 |
| Jun 12, 2026 | 4 | 0001573553-26-000002 |
| Jun 12, 2026 | 4 | 0001570392-26-000003 |
| Jun 12, 2026 | 4 | 0001634189-26-000002 |
| Jun 12, 2026 | 4 | 0001242215-26-000014 |
| Jun 12, 2026 | 4 | 0001616284-26-000002 |
| Jun 12, 2026 | 4 | 0001568850-26-000002 |
| Jun 12, 2026 | 4 | 0001970274-26-000004 |
| May 22, 2026 | EFFECT | 9999999995-26-001747 |
| May 15, 2026 | SCHEDULE 13G/A | 0001493215-26-000112 |
| May 13, 2026 | 10-Q | 0001104659-26-059752 |
| May 13, 2026 | S-3 | 0001104659-26-060391 |
| May 13, 2026 | 8-K | 0001104659-26-059780 |
| May 13, 2026 | SCHEDULE 13G/A | 0000919574-26-002920 |
| Apr 30, 2026 | DEF 14A | 0001104659-26-052880 |
| Apr 30, 2026 | ARS | 0001104659-26-052913 |
| Apr 30, 2026 | DEFA14A | 0001104659-26-052893 |
| Apr 20, 2026 | 4 | 0001437782-26-000010 |
| Apr 16, 2026 | 144 | 0001950047-26-003561 |
| Mar 26, 2026 | SCHEDULE 13G/A | 0001493152-26-013007 |
| Mar 23, 2026 | 3 | 0002012430-26-000002 |